Literature DB >> 23338958

Serum uric acid and slow coronary flow in cardiac syndrome X.

Z Elbasan1, D Y Sahin, M Gür, T Seker, A Kıvrak, S Akyol, Z Sümbül, O Kuloğlu, M Caylı.   

Abstract

OBJECTIVE: It has been recently shown that cardiac syndrome X (CSX) patients with slow coronary flow (SCF) have a worse long-term prognosis than those with normal coronary flow. Increased uric acid levels were shown to be associated with atherosclerosis, oxidative stress, and endothelial dysfunction. The purpose of the study was to investigate the relationship between coronary flow assessed with TIMI frame count (TFC) and serum uric acid (SUA) levels in patients with CSX.
METHODS: The study population consisted of 113 consecutive patients with typical cardiac CSX and 41 controls without cardiac CSX. Frequencies of risk factors as well as biochemical and hematological data were recorded for all participants. Coronary blood flow was evaluated by TFC. All patients with a TFC greater than two standard deviations from the published normal range for any one of the three vessels were accepted as having slow coronary flow (SCF group), while those whose TFC values fell within the standard deviation of the published normal range for all of the three vessels were considered to have normal coronary flow.
RESULTS: Of the 113 CSX patients enrolled, 40 (35.4%) had SCF. The mean TFC value was strongly positively correlated with SUA level, but weakly correlated with male sex, hypertension, diabetes, smoking, serum creatinine level, and hemoglobin. Multivariate regression analysis showed that only the SUA level was independently associated with SCF. The cut-off value for uric acid obtained by the ROC curve analysis was 4.55 mg/dl for the prediction of SCF (sensitivity, 77.5%; specificity, 73.6%).
CONCLUSION: The SUA level is independently associated with SCF in patients with CSX.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23338958     DOI: 10.1007/s00059-012-3735-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  19 in total

1.  Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries.

Authors:  Halil Tanriverdi; Harun Evrengul; Omur Kuru; Seyhan Tanriverdi; Deniz Seleci; Yasar Enli; H Asuman Kaftan; Mustafa Kilic
Journal:  Circ J       Date:  2006-05       Impact factor: 2.993

2.  Relationship between HbA₁c and coronary flow rate in patients with type 2 diabetes mellitus and angiographically normal coronary arteries.

Authors:  Mehmet Birhan Yılmaz; Alim Erdem; Osman Can Yontar; Savaş Sarıkaya; Ahmet Yılmaz; Nihat Madak; Filiz Karadaş; Izzet Tandoğan
Journal:  Turk Kardiyol Dern Ars       Date:  2010-09

3.  The relation between impaired glucose tolerance and slow coronary flow.

Authors:  Emrah Binak; Huseyin Gunduz; Muslum Sahin; Nuri Kurtoglu; Ismet Dindar
Journal:  Int J Cardiol       Date:  2005-11-16       Impact factor: 4.164

4.  Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries.

Authors:  E Mangieri; G Macchiarelli; M Ciavolella; F Barillà; A Avella; A Martinotti; L J Dell'Italia; G Scibilia; P Motta; P P Campa
Journal:  Cathet Cardiovasc Diagn       Date:  1996-04

5.  Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction.

Authors:  Min-A Yu; Laura G Sánchez-Lozada; Richard J Johnson; Duk-Hee Kang
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

6.  Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.

Authors:  Duk-Hee Kang; Sung-Kwang Park; In-Kyu Lee; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

7.  Slow coronary flow: a distinct angiographic subgroup in syndrome X.

Authors:  P K Goel; S K Gupta; A Agarwal; A Kapoor
Journal:  Angiology       Date:  2001-08       Impact factor: 3.619

Review 8.  Cardiac syndrome X: current concepts.

Authors:  Mukesh Singh; Sarabjeet Singh; Rohit Arora; Sandeep Khosla
Journal:  Int J Cardiol       Date:  2010-02-07       Impact factor: 4.164

9.  Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis.

Authors:  Gabriele Fragasso; Sergio L Chierchia; Francesco Arioli; Orazio Carandente; Stefano Gerosa; Mauro Carlino; Altin Palloshi; Luigi Gianolli; Giliola Calori; Ferruccio Fazio; Alberto Margonato
Journal:  Int J Cardiol       Date:  2008-08-31       Impact factor: 4.164

10.  Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study.

Authors:  J C Kaski; G M Rosano; P Collins; P Nihoyannopoulos; A Maseri; P A Poole-Wilson
Journal:  J Am Coll Cardiol       Date:  1995-03-15       Impact factor: 24.094

View more
  4 in total

1.  Predictors of slow flow in angiographically normal coronary arteries.

Authors:  Ibrahim Altun; Fatih Akin; Nuri Kose; Cem Sahin; Ismail Kirli
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Epicardial adipose tissue thickness is associated with myocardial infarction and impaired coronary perfusion.

Authors:  Aslı Tanındı; Sinan Altan Kocaman; Aycan Fahri Erkan; Murat Uğurlu; Aslıhan Alhan; Hasan Fehmi Töre
Journal:  Anatol J Cardiol       Date:  2014-02-26       Impact factor: 1.596

3.  Evaluation of serum platelet-derived growth factor receptor-ß and brain-derived neurotrophic factor levels in microvascular angina.

Authors:  Gamze Aslan; Veli Polat; Evin Bozcali; Mustafa Hakan Şahin; Nurcan Çetin; Dilek Ural
Journal:  Anatol J Cardiol       Date:  2020-12       Impact factor: 1.596

4.  Association of uric acid levels with cardiac syndrome X: A meta-analysis.

Authors:  Wu Zu; Chen-Chen Li; Xin-Yu Wang; Qiu-Shi Li; Bing Liu
Journal:  Front Physiol       Date:  2022-10-03       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.